Fund shareholders of TG THERAPEUTICS INC
ISIN US88322Q1085 · United States · LEI 529900X21UKABN9NJ529
- Fund shareholders
- 316
- Of which ETFs
- 84 232 other funds
- Value held
- ≈ 2.8B $ 2.8B $ · 15.6M SEK · 119.1K €
- Share of capital
- 35.4 % of 153.1M shares on Aug 3, 2026
316 funds hold this company. This table lists the 315 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. The “Fund reports” tab lists it, with its weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 288 | 15K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Motley Fool Innovative Growth Factor ETF RBB Fund, Inc. | 283 | 10.7K $ | 0.10 % | 0.00 % | as of May 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 276 | 14.4K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| JPMorgan Fundamental Data Science Small Core ETF J.P. Morgan Exchange-Traded Fund Trust | 269 | 14.8K $ | 0.16 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 216 | 11.9K $ | 0.16 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 165 | 9.1K $ | 0.25 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 160 | 6.1K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 136 | 5.2K $ | 0.02 % | 0.00 % | as of May 31, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 126 | 4.8K $ | 0.05 % | 0.00 % | as of May 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 123 | 6.4K $ | 0.08 % | 0.00 % | as of Jul 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 43 | 1.6K $ | 0.14 % | 0.00 % | as of May 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 41 | 2.3K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Dimensional US Sustainability Core 1 ETF Dimensional ETF Trust | 19 | 988.6 $ | 0.00 % | as of Jul 31, 2026 ↗ | |
| State Street(R) SPDR(R) S&P(R) 1500 Momentum Tilt ETF SPDR SERIES TRUST | 15 | 824.1 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| GVC GAESCO ZEBRA US SMALL CAPS LOW POPULARITY, FI GVC GAESCO GESTIÓN, SGIIC, S.A. | 119.1K € | 0.91 % | as of Dec 31, 2025 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 2.32 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| CapForce IBD Breakout Opportunities ETF Capital Force ETF Trust | 3.72 % | as of Jul 31, 2026 ↗ |
| CapForce IBD 50 ETF Capital Force ETF Trust | 3.52 % | as of Jul 31, 2026 ↗ |
| Congress Small Cap Growth Fund Professionally Managed Portfolios | 3.37 % | as of Jul 31, 2026 ↗ |
| Invesco S&P SmallCap Health Care ETF Invesco Exchange-Traded Fund Trust II | 2.75 % | as of May 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 2.32 % | as of Sep 30, 2025 ↗ |
| Invesco S&P SmallCap Quality ETF Invesco Exchange-Traded Fund Trust II | 2.25 % | as of May 31, 2026 ↗ |
| Invesco S&P SmallCap 600 GARP ETF Invesco Exchange-Traded Fund Trust II | 1.93 % | as of May 31, 2026 ↗ |
| ClearBridge Variable Small Cap Growth Portfolio Legg Mason Partners Variable Equity Trust | 1.66 % | as of Jun 30, 2026 ↗ |
| DANA EPIPHANY SMALL CAP EQUITY FUND Valued Advisers Trust | 1.61 % | as of Jul 31, 2026 ↗ |
| Penn Capital Special Situations Small Cap Equity Fund RBB Fund Trust | 1.52 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 312 | +29 | 54,083,982 | +2.4 % |
| 2026Q2 | 283 | +13 | 52,812,177 | -0.3 % |
| 2026Q1 | 270 | +11 | 52,984,448 | +2.2 % |
| 2025Q4 | 259 | -27 | 51,827,208 | -3.6 % |
| 2025Q3 | 286 | +3 | 53,758,868 | +2.8 % |
| 2025Q2 | 283 | +43 | 52,311,907 | -1.3 % |
| 2025Q1 | 240 | +17 | 52,980,916 | +5.7 % |
| 2024Q4 | 223 | +51 | 50,124,092 | +48.0 % |
| 2024Q3 | 172 | -2 | 33,867,902 | -10.7 % |
| 2024Q2 | 174 | +9 | 37,925,847 | +10.7 % |
| 2024Q1 | 165 | -6 | 34,258,917 | -6.2 % |
| 2023Q4 | 171 | 36,516,694 |
Institutional managers
354 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 22,252,930 | 739.2M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 8,649,766 | 287.3M $ | as of Mar 31, 2026 |
| Soleus Capital Management, L.P. | 4,029,319 | 133.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,499,916 | 116.3M $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 3,210,930 | 106.7M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,287,688 | 76M $ | as of Mar 31, 2026 |
| CONGRESS ASSET MANAGEMENT CO | 2,168,081 | 72M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 2,041,669 | 67.8M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,922,889 | 63.9M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 1,747,373 | 58M $ | as of Mar 31, 2026 |
| Hood River Capital Management LLC | 1,569,171 | 52.1M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,542,312 | 51.2M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,461,302 | 48.5M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 1,447,078 | 48.1M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 1,442,579 | 47.9M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,408,170 | 46.8M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,295,055 | 43M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,084,855 | 36M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 957,026 | 31.8M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 887,305 | 29.5M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 720,934 | 23.9M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 715,500 | 23.8M $ | as of Mar 31, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | 665,526 | 22.1M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 632,734 | 21K $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 590,047 | 19.6M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of TG THERAPEUTICS INC". https://titelia.com/en/stocks/tg-therapeutics-inc-US88322Q1085